194 related articles for article (PubMed ID: 7357511)
21. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3.
Tanaka Y; Bush KK; Klauck TM; Higgins PJ
Biochem Pharmacol; 1989 Nov; 38(21):3859-65. PubMed ID: 2688649
[TBL] [Abstract][Full Text] [Related]
22. Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells.
Joshi SS; Sinangil F; Sharp JG; Mathews NB; Volsky DJ; Brunson KW
Cancer Detect Prev; 1988; 11(3-6):405-17. PubMed ID: 3390859
[TBL] [Abstract][Full Text] [Related]
23. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
[TBL] [Abstract][Full Text] [Related]
24. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.
Blouin JM; Penot G; Collinet M; Nacfer M; Forest C; Laurent-Puig P; Coumoul X; Barouki R; Benelli C; Bortoli S
Int J Cancer; 2011 Jun; 128(11):2591-601. PubMed ID: 20715114
[TBL] [Abstract][Full Text] [Related]
25. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells.
López de Silanes I; Olmo N; Turnay J; González de Buitrago G; Pérez-Ramos P; Guzmán-Aránguez A; García-Díez M; Lecona E; Gorospe M; Lizarbe MA
Cancer Res; 2004 Jul; 64(13):4593-600. PubMed ID: 15231671
[TBL] [Abstract][Full Text] [Related]
26. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
Friend C; Zajac-Kaye M; Holland JG; Pogo BG
Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
[TBL] [Abstract][Full Text] [Related]
27. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate.
Nelson NF; Cieplak W; Dacus SC; Prager MD
Cancer Lett; 1987 Mar; 34(3):305-16. PubMed ID: 3548947
[TBL] [Abstract][Full Text] [Related]
28. Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line.
Zoref-Shani E; Lavie R; Bromberg Y; Beery E; Sidi Y; Sperling O; Nordenberg J
J Cancer Res Clin Oncol; 1994; 120(12):717-22. PubMed ID: 7798296
[TBL] [Abstract][Full Text] [Related]
29. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
30. Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax.
Barrasa JI; Santiago-Gómez A; Olmo N; Lizarbe MA; Turnay J
Biochim Biophys Acta; 2012 Dec; 1823(12):2201-9. PubMed ID: 22917577
[TBL] [Abstract][Full Text] [Related]
31. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29.
Gamet L; Daviaud D; Denis-Pouxviel C; Remesy C; Murat JC
Int J Cancer; 1992 Sep; 52(2):286-9. PubMed ID: 1521915
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
33. Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells.
Dexter DL; Lev R; McKendall GR; Mitchell P; Calabres P
Histochem J; 1984 Feb; 16(2):137-49. PubMed ID: 6698802
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
Goto I; Yamamoto-Yamaguchi Y; Honma Y
Br J Cancer; 1996 Aug; 74(4):546-54. PubMed ID: 8761368
[TBL] [Abstract][Full Text] [Related]
35. Effect of butyrate on glycolipid metabolism of two cell types of rat ascites hepatomas with different ganglioside biosynthesis.
Taki T; Hirabayashi Y; Kondo R; Matsumoto M; Kojima K
J Biochem; 1979 Nov; 86(5):1395-402. PubMed ID: 521438
[TBL] [Abstract][Full Text] [Related]
36. Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note.
Otaka M; Singhal A; Hakomori S
Biochem Biophys Res Commun; 1989 Jan; 158(1):202-8. PubMed ID: 2912449
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5.
Guzmán-Aránguez A; Olmo N; Turnay J; Lecona E; Pérez-Ramos P; López de Silanes I; Lizarbe MA
J Cell Biochem; 2005 Jan; 94(1):178-93. PubMed ID: 15526283
[TBL] [Abstract][Full Text] [Related]
38. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase.
Gum JR; Kam WK; Byrd JC; Hicks JW; Sleisenger MH; Kim YS
J Biol Chem; 1987 Jan; 262(3):1092-7. PubMed ID: 3805014
[TBL] [Abstract][Full Text] [Related]
39. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
40. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources.
Singh B; Halestrap AP; Paraskeva C
Carcinogenesis; 1997 Jun; 18(6):1265-70. PubMed ID: 9214612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
